Company Filing History:
1 out of 3 
1 out of 3 Years Active: 2010-2012
Title: **Elena Fingerut: Pioneering Innovations in Vaccinology**
Introduction
Elena Fingerut, an accomplished inventor based in Carmiel, Israel, has made significant contributions to the field of vaccinology. With two patents to her name, her work primarily focuses on adenoviral components that hold promise for effective vaccination methods.
Latest Patents
Elena's latest patents revolve around subunits of the adenovirus fiber protein and their applications as vaccines. One of her notable innovations includes a nucleic acid sequence that encodes a fragment of the adenovirus fiber capsid protein. This invention encompasses a DNA construct that features a replicable expression vector and at least one heterologous nucleic acid. Additionally, her work involves recombinant proteins that include a fragment of the adenovirus fiber capsid protein. Specifically, the fragment comprises the C-terminal knob and part of the shaft domain of the fiber protein from adenoviruses. These recombinant proteins have been identified as active ingredients in vaccinating compositions intended to provide immunity against adenoviral infections, particularly in domestic birds.
Career Highlights
Elena has garnered professional experience through her work with renowned companies in the biotechnology sector, including Abic Biological Laboratories and Teva Ltd. These roles have allowed her to nurture her expertise in biological research and vaccine development, contributing to the advancement of health sciences.
Collaborations
Throughout her career, Elena has collaborated with esteemed professionals in her field, including Jacob Pitcovski and Bezalel Gutter. These partnerships have played a vital role in enhancing her research endeavors and expanding the impact of her innovations.
Conclusion
Elena Fingerut exemplifies the spirit of innovation, particularly in the realm of vaccines. Through her groundbreaking patents and collaborative efforts, she continues to pave the way for advancements in immunology, offering hope for effective vaccines against adenoviral infections. Her work remains a critical piece of the larger puzzle in public health and disease prevention.